Contact: Steve Graff
Thomas Jefferson University
Caption: Abdolmohamad Rostami, M.D., Ph.D., professor and chairman of the Department of Neurology at Jefferson Medical College of Thomas Jefferson University, and colleagues have identified a driving force behind autoimmune diseases such as multiple sclerosis (MS), and suggest that blocking this cell-signaling molecule is the first step in developing new treatments to eradicate these diseases.
Usage Restrictions: None
Related news release: Blocking crucial molecule could help treat multiple sclerosis, Jefferson neuroscientists say